Stay Connected
Plugin created by StressFree Sites
-
Recent Posts
Recent Comments
- [BLOCKED BY STBV] Search and Social in Organ Donation Awareness | Christopher Taylor Barry, MD, PhD on Organ Donation: What Does it Take to Engender a Cultural Shift?
- [BLOCKED BY STBV] Dr. Barry’s Donate Life America Speech | Christopher Taylor Barry, MD, PhD on Linking Estate Planning with Organ Donation Registration
- [BLOCKED BY STBV] Deceased Donor Transplant Programs in India, Part 3: The Way Forward | Christopher Taylor Barry, MD, PhD on Deceased Donor Transplantation in India, Part 2: Indigenous Rackets and Transplant Tourism
- [BLOCKED BY STBV] Healthy Lifestyles for Healthy Organs | Christopher Taylor Barry, MD, PhD on Organ Donation Persuasive Speech: Dr. Chris Barry TEDx
- Healthy Lifestyles for Healthy Organs | Christopher Taylor Barry, MD, PhD on Deceased Donor Transplant Programs in India, Part 3: The Way Forward
Archives
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- February 2014
- January 2014
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- February 2013
- January 2013
- October 2012
- September 2012
- August 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- December 2011
- September 2011
- August 2011
- June 2011
- April 2011
- March 2011
Categories
Meta
Tag Archives: liver tumor ablation
Liver Transplant for Hepatocellular Carcinoma (HCC)
HCC, or HepatoCellular Carcinoma, is a type of cancer that begins in the liver. People with terminal scarring of their livers (cirrhosis), regardless of the original cause, are at higher risk of developing HCC. People infected with Hepatitis B or … Continue reading →
Posted in liver cancer treatment
|
Tagged Christopher Taylor Barry MD PhD, cirrhosis, Dr. Christopher Barry, HCC, hepatocellular carcinoma, liver cancer, liver transplant, liver tumor ablation, MELD, Milan Criteria, organ donation, personalized medicine, RFA.IRE, TACE, tumor embolization, University of Rochester Medical Center, URMC
|
Leave a comment
Why Biopsy Liver Cancer?
Liver cancers, especially when early in their genesis, are usually asymptomatic. Often they are detected when an ultrasound scan, a CT scan or MRI are performed for other reasons, or when a patient has underlying liver disease (cirrhosis of any … Continue reading →
Posted in liver cancer treatment, scholarship
|
Tagged Dr. Christopher Barry, genomics, laparoscopic liver surgery, liver biopsy, liver cancer, liver cancer genomics, liver disease, liver transplantation, liver tumor ablation, micro RNA, personalized medicine, RFA.IRE, sorafenib, TACE, University of Rochester Medical Center
|
1 Comment